Presentation, Management and Outcome of Penile Fractures in a Nigerian Tertiary Hospital

BackgroundPenile fracture is a relatively rare acquired urologic condition which may occur following blunt trauma to an erect penis. The aim of the study is to review the presentation, management and outcome of penile fractures in a tertiary hospital in Nigeria over a 7 year period.Patient and MethodsMedical records of 6 patients with diagnosis of penile fracture seen over a 7 year period were retrieved and information regarding the aaetiology, mode of presentation, treatment, outcome and follow up were recorded.ResultsThe mean age of the patients was 32.3 years. Blunt trauma during sexual intercourse was the mechanism of trauma in 5 patients. In one patient it was due to abrupt bending of an erect penis against tight underwear during foreplay. The mean time interval before presentation was 22 hours. All patients presented with the classical symptoms of penile pain, swelling and detumescence. All patients had immediate penile exploration and repair of tunica albuginea via a circumferential sub- coronal incision. The mean period of follow up after repair was 9.3 weeks. Penile erection and sexual function were satisfactory in all patients following repair. Complications noted included mild pain at the site of repair during sexual intercourse in 1patient and mild lateral deviation in another.ConclusionPenile fracture was a rare condition in this centre during the period. The immediate outcome of the repair of penile fracture is satisfactory. Long term follow up is needed to further evaluate patients with this condition.Key wordsPenile fracture, Tunica Albuginea, Repair, Outcom

In vitro effects of metals and pesticides on dehydrogenase activity in microbial community of cowpea (Vigna unguiculata) rhizoplane

Effects of heavy metals and pesticides on cowpea (Vigna unquiculata) rhizoplane microbial community  were assessed in vitro via dehydrogenase activity. The microbial community was exposed to various concentrations of heavy metals and pesticides in a nutrient broth-glucose-2,3,5-triphenyl chloride (TTC) medium. At 0.2 mM, iron and cadmium stimulated the dehydrogenase activity of the microbialcommunity. For all the metal ions, there was progressive inhibition with each successive increase in the concentration of metal ion, reaching near 100% at 0.6, 0.8, 1.2, 0.12 and 12 mM for cobalt, cadmium,iron, mercury and nickel, respectively. Between 0.2 and 0.4 mM, zinc sharply inhibited dehydrogenase activity and at concentration above 0.4 mm, inhibition of dehydrogenase activity became lesspronounced. The order of toxicity is Hg2+ > Co2+ > Cd2+ > Zn2+ > Fe2+ > Ni2+. The herbicides Cotrazine (Atrazine 80W) and Northrin®10EC stimulated dehydrogenase activity of the microbial community at 0.2% and inhibited it at higher concentrations. The median inhibitory concentrations (IC50s) of Cotrazine(Atrazine 80W) and Northrin®10EC were 0.552 ± 0.028 and 0.593 ± 0.051%, respectively. The dehydrogenase activity varied significantly (p < 0.05) with the type and concentrations of metals orpesticides. The result indicates that the heavy metals and pesticides are potentially toxic to V. unquiculata root surface microorganisms. In soil, this toxicity may affect nitrogen fixation processes and by extrapolation affect crop yield

Pentanol isomer synthesis in engineered microorganisms

Pentanol isomers such as 2-methyl-1-butanol and 3-methyl-1-butanol are a useful class of chemicals with a potential application as biofuels. They are found as natural by-products of microbial fermentations from amino acid substrates. However, the production titer and yield of the natural processes are too low to be considered for practical applications. Through metabolic engineering, microbial strains for the production of these isomers have been developed, as well as that for 1-pentanol and pentenol. Although the current production levels are still too low for immediate industrial applications, the approach holds significant promise for major breakthroughs in production efficiency

Role of Stem Cells in Human Uterine Leiomyoma Growth

Uterine leiomyoma is the most common benign tumor in reproductive-age women. Each leiomyoma is thought to be a benign monoclonal tumor arising from a single transformed myometrial smooth muscle cell; however, it is not known what leiomyoma cell type is responsible for tumor growth. Thus, we tested the hypothesis that a distinct stem/reservoir cell-enriched population, designated as the leiomyoma-derived side population (LMSP), is responsible for cell proliferation and tumor growth.LMSP comprised approximately 1% of all leiomyoma and 2% of all myometrium-derived cells. All LMSP and leiomyoma-derived main population (LMMP) but none of the side or main population cells isolated from adjacent myometrium carried a mediator complex subunit 12 mutation, a genetic marker of neoplastic transformation. Messenger RNA levels for estrogen receptor-α, progesterone receptor and smooth muscle cell markers were barely detectable and significantly lower in the LMSP compared with the LMMP. LMSP alone did not attach or survive in monolayer culture in the presence or absence of estradiol and progestin, whereas LMMP readily grew under these conditions. LMSP did attach and survive when directly mixed with unsorted myometrial cells in monolayer culture. After resorting and reculturing, LMSP gained full potential of proliferation. Intriguingly, xenografts comprised of LMSP and unsorted myometrial smooth muscle cells grew into relatively large tumors (3.67 ± 1.07 mm(3)), whereas xenografts comprised of LMMP and unsorted myometrial smooth muscle cells produced smaller tumors (0.54 ± 0.20 mm(3), p<0.05, n = 10 paired patient samples). LMSP xenografts displayed significantly higher proliferative activity compared with LMMP xenografts (p<0.05).Our data suggest that LMSP, which have stem/reservoir cell characteristics, are necessary for in vivo growth of leiomyoma xenograft tumors. Lower estrogen and progesterone receptor levels in LMSP suggests an indirect paracrine effect of steroid hormones on stem cells via the mature neighboring cells

MED12 Alterations in Both Human Benign and Malignant Uterine Soft Tissue Tumors

The relationship between benign uterine leiomyomas and their malignant counterparts, i.e. leiomyosarcomas and smooth muscle tumors of uncertain malignant potential (STUMP), is still poorly understood. The idea that a leiomyosarcoma could derive from a leiomyoma is still controversial. Recently MED12 mutations have been reported in uterine leiomyomas. In this study we asked whether such mutations could also be involved in leiomyosarcomas and STUMP oncogenesis. For this purpose we examined 33 uterine mesenchymal tumors by sequencing the hot-spot mutation region of MED12. We determined that MED12 is altered in 66.6% of typical leiomyomas as previously reported but also in 11% of STUMP and 20% of leiomyosarcomas. The mutated allele is predominantly expressed in leiomyomas and STUMP. Interestingly all classical leiomyomas exhibit MED12 protein expression while 40% of atypical leiomyomas, 50% of STUMP and 80% of leiomyosarcomas (among them the two mutated ones) do not express MED12. All these tumors without protein expression exhibit complex genomic profiles. No mutations and no expression loss were identified in an additional series of 38 non-uterine leiomyosarcomas. MED12 mutations are not exclusive to leiomyomas but seem to be specific to uterine malignancies. A previous study has suggested that MED12 mutations in leiomyomas could lead to Wnt/β-catenin pathway activation however our immunohistochemistry results show that there is no association between MED12 status and β-catenin nuclear/cytoplasmic localization. Collectively, our results show that subgroups of benign and malignant tumors share a common genetics. We propose here that MED12 alterations could be implicated in the development of smooth muscle tumor and that its expression could be inhibited in malignant tumors

The burden, distribution and risk factors for cervical oncogenic human papilloma virus infection in HIV positive Nigerian women

Background: The expected reduction in cervical cancer incidence as a result of increased access to antiretroviral therapy is yet to be seen. In this study we investigated the effect of HIV infection and treatment on high-risk (hr) human papilloma virus (HPV) prevalence and distribution. Methods: Cervical cells from 515 (220 HIV positive and 295 HIV negative) women, recruited during community cervical cancer screening programme in states of Ogun and Lagos and at the cervical cancer screen clinic, Nigerian Institute of Medical Research Lagos were evaluated for the presence of 13 hr HPV genotypes by polymerase chain reaction based assay. Results: The prevalence of high-risk HPV was 19.6% in the studied population. HPV 16 (3.9%), 35 (3.5%), 58 (3.3%) and 31 (3.3%) were the most common hr HPV infections detected. We observed that the prevalence of hr HPV was higher in HIV positives (24.5%) than 15.9% in HIV negative women (OR = 1.7; 95% CI: 1.1-2.7). A multivariate logistic regression analysis showed a lower hr HPV prevalence in HIV positive women on antiretroviral drugs (OR = 0.4; 95% CI: 0.3-0.5) and with CD4 count of 500 and above (OR = 0.7; 95% CI: 0.5-0.8). A higher prevalence of hr HPV was also noted in HIV positive women with CD4 count <200 cells/mm3 (OR = 2.4; 95% CI: 1.7-5.9). Conclusion: HPV 16, 35, 58 and 31 genotypes were the most common hr HPV infection in our study group, which could be regarded as high risk general population sample; with higher prevalence of HPV 16 and 35 in HIV positive women than in HIV negative women. The use of antiretroviral drugs was found to be associated with a lower prevalence of hr HPV infection, compared to those not on treatment. This study raises important issues that should be further investigated to enable the development of robust cervical cancer prevention and control strategies for women in our setting

Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes

<p>Abstract</p> <p>Background</p> <p>In a previous pooled analysis of 12 double-blind clinical studies that included data on 6,139 patients with type 2 diabetes, treatment with sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, was shown to be generally well tolerated compared with treatment with control agents. As clinical development of sitagliptin continues, additional studies have been completed, and more patients have been exposed to sitagliptin. The purpose of the present analysis is to update the safety and tolerability assessment of sitagliptin by pooling data from 19 double-blind clinical studies.</p> <p>Methods</p> <p>The present analysis included data from 10,246 patients with type 2 diabetes who received either sitagliptin 100 mg/day (N = 5,429; sitagliptin group) or a comparator agent (placebo or an active comparator) (N = 4,817; non-exposed group). The 19 studies from which this pooled population was drawn represent the double-blind, randomized studies that included patients treated with the usual clinical dose of sitagliptin (100 mg/day) for between 12 weeks and 2 years and for which results were available as of July 2009. These 19 studies assessed sitagliptin taken as monotherapy, initial combination therapy with metformin or pioglitazone, or as add-on combination therapy with other antihyperglycemic agents (metformin, pioglitazone, a sulfonylurea ± metformin, insulin ± metformin, or rosiglitazone + metformin). Patients in the non-exposed group were taking placebo, metformin, pioglitazone, a sulfonylurea ± metformin, insulin ± metformin, or rosiglitazone + metformin. The analysis used patient-level data from each study to evaluate between-group differences in the exposure-adjusted incidence rates of adverse events.</p> <p>Results</p> <p>Summary measures of overall adverse events were similar in the sitagliptin and non-exposed groups, except for an increased incidence of drug-related adverse events in the non-exposed group. Incidence rates of specific adverse events were also generally similar between the two groups, except for increased incidence rates of hypoglycemia, related to the greater use of a sulfonylurea, and diarrhea, related to the greater use of metformin, in the non-exposed group and constipation in the sitagliptin group. Treatment with sitagliptin was not associated with an increased risk of major adverse cardiovascular events.</p> <p>Conclusions</p> <p>In this updated pooled safety analysis of data from 10,246 patients with type 2 diabetes, sitagliptin 100 mg/day was generally well tolerated in clinical trials of up to 2 years in duration.</p

Alternative low-cost adsorbent for water and wastewater decontamination derived from eggshellwaste: an overview

As the current global trend towards more stringent environmental standards, technical applicability and cost-effectiveness became key factors in the selection of adsorbents for water and wastewater treatment. Recently, various low-cost adsorbents derived from agricultural waste, industrial by-products or natural materials, have been intensively investigated. In this respect, the eggshells from egg-breaking operations constitute significant waste disposal problems for the food industry, so the development of value-added by-products from this waste is to be welcomed. The egg processing industry is very competitive, with low profit margins due to global competition and cheap imports. Additionally, the costs associated with the egg shell disposal (mainly on landfill sites) are significant, and expected to continue increasing as landfill taxes increase. The aim of the present review is to provide an overview on the development of low-cost adsorbents derived from eggshell by-products

Purification and characterization of &#223-Glucosidase produced by Paecilomyces SP

No abstractKeywords:&#223-glucosidase; corn cob; gel filtration; half life; ion exchange chromatography; Paecilomyces sp.Global Journal of Pure and Applied Sciences Vol. 11(3) 2005: 357-36

Optimising crude oil biodegradation in a sandy loam soil using a mixture of cow dung and poultry manure

The impacts of addition of cow dung and poultry manure alone and in combination with surfactants and/or alternate carbon substrates on crude oil biodegradation in a sandy loam soil were investigated. At a 1.0% (w/w) concentration of the mixture of cow dung and poultry manure, addition of the alternate carbon substrates alone reduced the extent of crude oil degradation relative to an un-amended control, while addition of the surfactants alone lowered oil degradation than was obtained when added together with the alternate carbon substrates. Optimal crude oil degradations were obtained at a 4.0% (w/w) concentration of the mixture of cow dung and poultry manure added alone or at 2.0% (w/w) of the mixture in combination with Corexit (0.1% v/w) + glucose (1.0% w/w). The highest crude oil degradation of 11.58 ±1.64% relative to an un-amended control was obtained after sixteen weeks incubation from sample treated with only the mixture of cow dung and poultry manure at 4.0% (w/w).Keywords: crude oil degradation, cow dung, poultry manure, surfactants, alternate carbon substratesInternational Journal of Agriculture and Rural Development Vol. 5 2004: 69-7